Breaking News Instant updates and real-time market news.

DOVA

Dova Pharmaceuticals

$24.35

-0.92 (-3.64%)

04:55
04/24/18
04/24
04:55
04/24/18
04:55

Dova Pharmaceuticals management to meet with Jefferies

Meetings to be held in San Francisco on April 23 and in Chicago/Denver on April 24 hosted by Jefferies.

  • 24

    Apr

  • 21

    May

DOVA Dova Pharmaceuticals
$24.35

-0.92 (-3.64%)

08/31/17
RAJA
08/31/17
NO CHANGE
RAJA
Market Perform
Investors wrong to think Fosun will acquire Impax, says Raymond James
Raymond James analyst Elliot Wilbur says shares of Impax Laboratories (IPXL) are up 20% after Shanghai Fosun Pharmaceutical disclosed this morning a 5.19% stake in the company. Investors interpreting the investment as strategic, setting up an eventual takeover of Impax, is inaccurate, Wilbur tells investors in a research note. The analyst points out that Shanghai Fosun has a New York-based investment arm with positions in companies including Valeant Pharmaceuticals (VRX), Dova Pharmaceuticals (DOVA) and Nature's Sunshine Products (NATR). The stake is just a passive investment made because the investment arm of Shanghai Fosun believes in the Impax turnaround story "and nothing more," Wilbur contends. He keeps a Market Perform rating on Impax. The stock in afternoon trading is up 20%, or $3.62, to $21.58.
09/26/17
LEER
09/26/17
UPGRADE
LEER
Outperform
Dova Pharmaceuticals upgraded to Outperform from Market Perform at Leerink
09/26/17
09/26/17
UPGRADE
Target $32

Outperform
Dova Pharmaceuticals upgraded to Outperform at Leerink
As previously reported, Leerink analyst Geoffrey Porges upgraded Dova Pharmaceuticals to Outperform from Market Perform after Shionogi announced results from its phase III trial investigating thrombopoietin receptor agonist lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing an invasive procedure. The analyst notes that lusutrombopag is from the same class of drugs as Dova's avatrombopag, but is less effective ex-Japan, and believes Dova's avatrombopag has advantage. Porges also raised his price target on Dova's shares to $32 from $24.
11/28/17
JEFF
11/28/17
NO CHANGE
Target $33
JEFF
Buy
Dova Pharmaceuticals price target raised to $33 from $30 at Jefferies
Jefferies analyst Eun Yang raised her price target for Dova Pharmaceuticals to $33 after avatrombopag received FDA priority review with an action date of May 21, 2018. The analyst sees a higher probability for regulatory success of 95% and potential approval three months earlier than previously thought. She keeps a Buy rating on Dova.

TODAY'S FREE FLY STORIES

AMRN

Amarin

$10.00

7 (233.33%)

10:00
09/24/18
09/24
10:00
09/24/18
10:00
Options
Active trading in Amarin as shares surge »

Active trading in Amarin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

KORS

Michael Kors

$68.56

-4.11 (-5.66%)

10:00
09/24/18
09/24
10:00
09/24/18
10:00
Hot Stocks
Michael Kors falls -5.7% »

Michael Kors is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$5.55

-0.32 (-5.45%)

10:00
09/24/18
09/24
10:00
09/24/18
10:00
Hot Stocks
Britannia Bulk falls -5.7% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPDF

PPDAI Group

$6.07

-0.53 (-8.03%)

10:00
09/24/18
09/24
10:00
09/24/18
10:00
Hot Stocks
PPDAI Group falls -8.0% »

PPDAI Group is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SA

Seabridge Gold

$12.80

1.55 (13.78%)

10:00
09/24/18
09/24
10:00
09/24/18
10:00
Hot Stocks
Seabridge Gold rises 12.9% »

Seabridge Gold is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

CRC

California Resources

$44.89

5.36 (13.56%)

10:00
09/24/18
09/24
10:00
09/24/18
10:00
Hot Stocks
California Resources rises 13.5% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

XON

Intrexon

$17.02

2.525 (17.42%)

10:00
09/24/18
09/24
10:00
09/24/18
10:00
Hot Stocks
Intrexon rises 17.5% »

Intrexon is up 17.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:57
09/24/18
09/24
09:57
09/24/18
09:57
General news
Market starts lower as new tariffs ratchet up China tensions »

Stock futures were weak…

C

Citi

$74.33

0.2 (0.27%)

09:55
09/24/18
09/24
09:55
09/24/18
09:55
Options
Citi put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 28

    Sep

  • 21

    Oct

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 12

    Oct

EW

Edwards Lifesciences

$161.52

7.81 (5.08%)

, ALXN

Alexion

$128.15

6.18 (5.07%)

09:55
09/24/18
09/24
09:55
09/24/18
09:55
Options
Early notable gainers among liquid option names on September 24th »

Notable gainers among…

EW

Edwards Lifesciences

$161.52

7.81 (5.08%)

ALXN

Alexion

$128.15

6.18 (5.07%)

APA

Apache

$47.61

1.665 (3.62%)

ABT

Abbott

$71.27

2.22 (3.22%)

NFX

Newfield Exploration

$29.85

0.81 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 17

    Oct

  • 18

    Feb

09:55
09/24/18
09/24
09:55
09/24/18
09:55
Conference/Events
UBS consumer goods analyst to hold an analyst/industry conference call »

Consumer Goods Analyst…

SBAC

SBA Communications

$159.90

-0.62 (-0.39%)

09:54
09/24/18
09/24
09:54
09/24/18
09:54
Conference/Events
SBA Communications management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

09:50
09/24/18
09/24
09:50
09/24/18
09:50
General news
Florence Fallout: »

Florence Fallout:…

09:49
09/24/18
09/24
09:49
09/24/18
09:49
Conference/Events
RBC Capital equity strategy analyst to hold an analyst/industry conference call »

U.S. Equity Strategy…

RHHBY

Roche

$0.00

(0.00%)

09:49
09/24/18
09/24
09:49
09/24/18
09:49
Hot Stocks
Genentech: Tecentriq + chemotherapy reduced risk of disease worsening in trial »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Oct

UNFI

United Natural Foods

$30.73

-0.29 (-0.93%)

09:47
09/24/18
09/24
09:47
09/24/18
09:47
Recommendations
United Natural Foods analyst commentary  »

United Natural Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

YEXT

Yext

$23.24

-1.53 (-6.18%)

09:47
09/24/18
09/24
09:47
09/24/18
09:47
Hot Stocks
Yext falls -5.4% »

Yext is down -5.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

09:47
09/24/18
09/24
09:47
09/24/18
09:47
Hot Stocks
Genentech's Entrectinib showed durable response rate of over 2 years in NSCLC »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Oct

DWT

Britannia Bulk

$5.57

-0.3 (-5.11%)

09:47
09/24/18
09/24
09:47
09/24/18
09:47
Hot Stocks
Britannia Bulk falls -5.3% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPDF

PPDAI Group

$6.01

-0.59 (-8.94%)

09:47
09/24/18
09/24
09:47
09/24/18
09:47
Hot Stocks
PPDAI Group falls -9.5% »

PPDAI Group is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$9.65

0.57 (6.28%)

09:47
09/24/18
09/24
09:47
09/24/18
09:47
Hot Stocks
Pandora rises 6.2% »

Pandora is up 6.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XON

Intrexon

$16.14

1.645 (11.35%)

09:47
09/24/18
09/24
09:47
09/24/18
09:47
Hot Stocks
Intrexon rises 12.1% »

Intrexon is up 12.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SA

Seabridge Gold

$12.45

1.2 (10.67%)

09:47
09/24/18
09/24
09:47
09/24/18
09:47
Hot Stocks
Seabridge Gold rises 10.6% »

Seabridge Gold is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

HKMPY

Hikma

$0.00

(0.00%)

09:45
09/24/18
09/24
09:45
09/24/18
09:45
Conference/Events
Hikma has a conference call hosted by JPMorgan »

JPMorgan Analyst Gordon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

09:43
09/24/18
09/24
09:43
09/24/18
09:43
Conference/Events
The National Press Club to host a luncheon meeting »

Craig Newmark, founder of…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.